DI CHIARA, Tiziana
 Distribuzione geografica
Continente #
NA - Nord America 4.891
EU - Europa 3.205
AS - Asia 2.451
SA - Sud America 399
AF - Africa 61
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 11.012
Nazione #
US - Stati Uniti d'America 4.813
IT - Italia 996
SG - Singapore 899
RU - Federazione Russa 757
CN - Cina 661
BR - Brasile 316
FI - Finlandia 314
HK - Hong Kong 268
VN - Vietnam 249
DE - Germania 244
UA - Ucraina 204
PL - Polonia 150
GB - Regno Unito 134
FR - Francia 116
IE - Irlanda 116
JP - Giappone 71
IN - India 60
KR - Corea 43
SE - Svezia 38
CA - Canada 37
NL - Olanda 31
AR - Argentina 25
BD - Bangladesh 25
IQ - Iraq 25
MX - Messico 25
RO - Romania 22
TR - Turchia 21
BE - Belgio 20
AT - Austria 18
ZA - Sudafrica 18
EC - Ecuador 16
PK - Pakistan 15
CL - Cile 14
MY - Malesia 14
PH - Filippine 13
VE - Venezuela 13
ES - Italia 11
IR - Iran 11
UZ - Uzbekistan 10
NP - Nepal 9
MA - Marocco 8
SA - Arabia Saudita 8
CI - Costa d'Avorio 7
LT - Lituania 7
CH - Svizzera 6
OM - Oman 6
AZ - Azerbaigian 5
CO - Colombia 5
DZ - Algeria 5
ID - Indonesia 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
DO - Repubblica Dominicana 4
IL - Israele 4
JO - Giordania 4
PE - Perù 4
TH - Thailandia 4
AO - Angola 3
BG - Bulgaria 3
EG - Egitto 3
ET - Etiopia 3
HR - Croazia 3
JM - Giamaica 3
KE - Kenya 3
KG - Kirghizistan 3
SN - Senegal 3
TN - Tunisia 3
AL - Albania 2
BH - Bahrain 2
BO - Bolivia 2
CG - Congo 2
CR - Costa Rica 2
DK - Danimarca 2
GE - Georgia 2
HN - Honduras 2
KZ - Kazakistan 2
LU - Lussemburgo 2
PA - Panama 2
PT - Portogallo 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
UY - Uruguay 2
AM - Armenia 1
BB - Barbados 1
BY - Bielorussia 1
CY - Cipro 1
EE - Estonia 1
GA - Gabon 1
GY - Guiana 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
MN - Mongolia 1
MU - Mauritius 1
NI - Nicaragua 1
PY - Paraguay 1
RS - Serbia 1
SC - Seychelles 1
TT - Trinidad e Tobago 1
Totale 11.010
Città #
Ashburn 662
Singapore 604
Fairfield 455
Chandler 330
San Jose 297
Hong Kong 263
Woodbridge 260
Seattle 194
Wilmington 186
Houston 165
Ann Arbor 151
Moscow 149
Palermo 143
Zgierz 128
Cambridge 123
Dallas 121
Council Bluffs 119
Dublin 116
Beijing 101
Jacksonville 100
New York 90
Des Moines 88
Ho Chi Minh City 87
Medford 86
Santa Clara 79
Los Angeles 73
Frankfurt am Main 68
Tokyo 67
Milan 65
Rome 64
Helsinki 63
Nanjing 62
Hefei 59
Altamura 58
The Dalles 58
Lauterbourg 56
Hanoi 55
Princeton 54
Buffalo 42
Lawrence 39
San Diego 37
São Paulo 31
Tulsa 29
Boardman 28
Dearborn 28
Jinan 27
Hebei 26
Shenyang 26
Florence 22
London 22
Nanchang 22
Chicago 21
Amsterdam 20
Orem 20
Columbus 19
Brussels 18
Tianjin 17
Changsha 16
Da Nang 15
Naples 14
Phoenix 14
Seongnam 14
Verona 14
Falls Church 13
Hangzhou 13
Johannesburg 13
Ludwigshafen am Rhein 13
Nuremberg 13
Springfield 13
Warsaw 13
Auburn Hills 12
Chennai 12
Guangzhou 12
Kumar 12
Zhengzhou 12
Denver 11
Grassobbio 11
Jiaxing 11
Montreal 11
Stockholm 11
City of London 10
Düsseldorf 10
Mumbai 10
Santiago 10
Shanghai 10
Tashkent 10
Turin 10
Izmir 9
Ottawa 9
Rio de Janeiro 9
San Mateo 9
Tehran 9
Baghdad 8
Bologna 8
Munich 8
Ningbo 8
Poplar 8
Taizhou 8
Venice 8
Abidjan 7
Totale 6.864
Nome #
Obesità e rischio cardiovascolare. 576
A family with various symptomatology suggestive of Anderson-Fabry disease and a genetic polymorphism of alpha galactosidase A gene 304
Antihypertensive and cardiovascular effects of combined blockade of renin-angiotensin system with ACE inhibitor and angiotensin II type 1 receptor blocker in hypertensive patients: a 24 week randomized controlled double-dummy trial. 285
Inter-familial and intra-familial phenotypic variability in three Sicilian families with Anderson-Fabry disease. 250
May Adiponectin be considered as a Novel Cardiometabolic Biomarker? 233
Association between low education and higher global cardiovascular risk 229
Genetics and gene therapy of anderson-fabry disease 229
L’obesità fattore o co-fattore di rischio? 226
Hypoadiponectinemia, cardiometabolic comorbidities and left ventricular hypertrophy 222
Circulating adiponectin: a cardiometabolic marker associated with global cardiovascular risk 221
Improving efficacy of PubMed Clinical Queries for retrieving scientifically strong studies on treatment. 219
Relationship between circulating E-selectin, DD genotype of angiotensin-converting-enzyme, and cardiovascular damage in central obese subjects 211
Plasma adiponectin: A contributing factor for cardiac changes in visceral obesity-associated hypertension 211
Take the wind out your salis: relationship among energy drink abuse, hypertension, and break-up of cerebral aneurysm 210
Endothelial nitric oxide synthase gene polymorphisms and cardiovascular damage in hypertensive subjects: an Italian case-control study. 204
Hypoadiponectinemia: A Link between Visceral Obesity and Metabolic Syndrome. 200
Effect of dual blockade of renin-angiotensin system on TGF beta 1 and left ventricular structure and function in hypertensive patients 198
Education and hypertension: impact on global cardiovascular risk 195
Right ventricular diameter predicts all-cause mortality in heart failure with preserved ejection fraction 194
Visceral obesity and metabolic syndrome: two faces of the same medal? 193
Effects of cilazapril on renal haemodynamics and function in hypertensive patients: a randomised controlled study versus hydrochlorothiazide 191
Assessment of heart rate variability (HRV) in subjects with type 2 diabetes mellitus with and without diabetic foot: correlations with endothelial dysfunction indices and markers of adipo-inflammatory dysfunction 189
Effetti cardioprotettivi del Blocco del Sistema Renina-Angiotensina-Aldosterone tramite l’associazione ACE-inibitore – Sartani: Relazione con i livelli circolanti di Transforming Growth Factor ß1. 188
Hemostatic function in young subjects with central obesity: relationship with left ventricular function 186
A case of infective colitis due to Yersinia enterocolitica complicated by microliver abscesses mimicking multiple liver occult metastases: a case report 186
IgG4 Related Syndrome: Another Multiorgan Disease in the Interest Field of Internal Medicine. 185
Efficacy of dulaglutide on vascular health indexes in subjects with type 2 diabetes: a randomized trial 184
The Relationship between the Transforming Growth Factor β1 T29C Gene Polymorphism and Left Ventricular Geometry and Function in Hypertensive Subjects 183
Associazione tra elevate livelli circolanti di Transforming growth factor ß1 (TGF ß1) ed alterato riempimento ventricolare sinistro in una popolazione di soggetti ipertesi. 182
Effects of intravenous furosemide plus small-volume hypertonic saline solutions on markers of heart failure 178
Left ventricular filling abnormalities and obesity-associated hypertension: relationship with overproduction of circulating transforming growth factor beta1. 176
DIASTOLIC DYSFUNCTION AND CENTRAL OBESITY RELATED HYPERTENSION: ROLE OF TRASFORMING GROWTH FACTOR BETA-1 176
Obesity related changes in cardiac structure and function: role of blood pressure and metabolic abnormalities. 176
Can Be miR-126-3p a Biomarker of Premature Aging? An Ex Vivo and In Vitro Study in Fabry Disease 175
Central obesity and hypertensive renal disease: association between higher levels of BMI, circulating transforming growth factor beta1 and urinary albumin excretion. 173
DIASTOLIC DYSFUNCTION AND CENTRAL OBESITY RELATED HYPERTENSION: ROLE OF TRANSFORMING GROWTH FACTOR BETA-1 163
Associazione tra elevati livelli circolanti di Transforming growth factor ß1 (TGF ß1) e alterato riempimento ventricolare sinistro in una popolazione di soggetti ipertesi. 160
Heredity and obesity-associated hypertension: impact of hormonal characteristics and left ventricular mass. J Hypertens 158
Obesity and cardiovascular risk: the new public health problem of worldwide proportions. 157
Metabolic memory in diabetic foot syndrome (DFS): MICRO-RNAS, single nucleotide polymorphisms (SNPs) frequency and their relationship with indices of endothelial function and adipo-inflammatory dysfunction 155
Pathogenesis and molecular mechanisms of anderson–fabry disease and possible new molecular addressed therapeutic strategies 151
Obesity: a main factor of metabolic syndrome? 146
Effects of the Mediterranean Diet on the Components of Metabolic Syndrome Concerning the Cardiometabolic Risk 140
Vascular health in subjects with rheumatoid arthritis: assessment of endothelial function indices and serum biomarkers of vascular damage 138
Transforming growth factor beta1 and additional renoprotective effect of combination ACE inhibitor and angiotensin II receptor blocker in hypertensive subjects with minor renal abnormalities: a 24-week randomized controlled trial 133
Prevalence of obesity and ischaemic heart disease in hypertensive subjects 132
Genetic polymorphisms and cytokine levels in ischemic stroke: associations with subtypes and prognosis 131
Nutrizione,sovrappeso e sindrome metabolica 129
Paraneoplastic Cerebellar Degeneration Associated with Breast Cancer: A Case Report and a Narrative Review 128
Iperuricemia: significato clinico e nuove prospettive di trattamento 114
Molecular Mechanisms of Inflammasome in Ischemic Stroke Pathogenesis 114
Mediterranean diet effects on vascular health and serum levels of adipokines and ceramides 112
Sindrome Metabolica 112
Micro-albuminuria in obese subjects: relationship among body fat distribution, blood pressure and left ventricular structure and function. 111
La terapia dietetica nell’insufficienza renale cronica. 109
Multiplex Ligation Probe Amplification and Sanger Sequencing: Light and Shade in the Diagnosis of Lysosomal Storage Disorders 108
Sindrome metabolica: fatti e compromessi. 106
Identification of Novel Mutations in Patients Affected by Gaucher Disease 103
Scompenso cardiaco da disfunzione diastolica. 103
Transforming growth factor beta1 ed effetto nefroprotettivo dell’associazione ACE-inibitori-AT1 antagonista in soggetti ipertesi con iniziale danno renale 100
Mediterranean diet and hypertension: relationship between adherence to a Mediterranean diet and arterial hypertension 95
Identification of Four New Mutations in the GLA Gene Associated with Anderson–Fabry Disease 90
Transforming growth factor β1 T29C gene polymorphism and hypertension: Relationship with cardiovascular and renal damage 86
Transforming growth factor β1 and additional renoprotective effect of combination ACE inhibitor and angiotensin II receptor blocker in hypertensive subjects with minor renal abnormalities: A 24-week randomized controlled trial 81
Pathogenetic Mechanisms of Hypertension–Brain-Induced Complications: Focus on Molecular Mediators 76
Il paziente iperteso ad alto rischio cadiovascolare 74
null 51
null 42
Totale 11.346
Categoria #
all - tutte 36.724
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.724


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021157 0 0 0 0 0 0 0 0 0 0 91 66
2021/2022725 28 127 16 29 67 27 40 48 77 91 43 132
2022/20231.028 86 166 36 107 99 154 75 78 145 13 43 26
2023/2024466 27 57 20 37 33 94 41 33 8 18 17 81
2024/20251.281 25 78 58 107 52 33 130 77 95 119 187 320
2025/20264.495 339 100 325 353 536 699 743 484 308 556 52 0
Totale 11.346